Thermo Fisher Enters into New $1.5B Credit Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Friday that it has entered into a new $1.5 billion credit agreement, replacing the existing $1 billion revolving credit agreement.

The new agreement is a five-year senior unsecured revolving facility, Thermo Fisher said in a document filed with the US Securities and Exchange Commission. Thermo Fisher entered into the new agreement on July 25.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.